Cardio-Kidney-Metabolic Phenotypes in Atrial Fibrillation

JACC Asia. 2026 May;6(5):809-812. doi: 10.1016/j.jacasi.2026.03.017.

¹ Liverpool Centre for Cardiovascular Sciences at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy; Internal Medicine and Nephrology Division, ASL1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy. Electronic address: leandra.serio@liverpool.ac.uk.
² Liverpool Centre for Cardiovascular Sciences at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
³ Liverpool Centre for Cardiovascular Sciences at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Medical University of Bialystok, Bialystok, Poland.

No abstract available

Keywords: atrial fibrillation; cardiokidney-metabolic phenotype; major adverse kidney events.

Publication types